What is the Heron Therapeutics Inc (HRTX) price today?

The price of Heron Therapeutics Inc (HRTX) today is $0.85. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/HRTX

Buy & Sell Heron Therapeutics Inc (HRTX) – Heron Therapeutics Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

HRTX trades at $0.7992, down 0.54% on the day, with a bearish technical signal from moving averages. The company reported 2025 revenue of $155 million but a net loss of $20 million, with a negative net income margin of -13.04%. Recent news highlights Q4 2025 earnings and full-year 2026 revenue guidance of $173 to $183 million, driven by growth in its acute care franchise.

The outlook is mixed: strong analyst consensus (100% buy ratings) and positive revenue guidance contrast with persistent losses and bearish technicals. Key risks include execution on profitability targets and competitive pressures in biotechnology. Upside depends on achieving adjusted EBITDA guidance of $10 to $20 million for 2026.

Read full analysis

Key Stats

Market Cap
$148.94M
Sector
Health
3M Drawdown
-49.94%
Enterprise Value
$244.00M
Dividend Yield
-
Trading Activity
85% Buy | 15% Sell
Typical Hold Time
12 days

$0.85

52W Low: $0.75

30 Mar 2026

52W High: $2.42

06 May 2025

Heron Therapeutics Inc (HRTX) is currently valued at a market capitalization of $148.94M, with an enterprise value of $244.00M. Over the past 52 weeks, Heron Therapeutics Inc has traded between a low of $0.75 and a high of $2.42, highlighting its annual price range. Over the past three months, Heron Therapeutics Inc has recorded a drawdown of -49.94%, reflecting recent price volatility. Heron Therapeutics Inc offers a dividend yield of -. On average, investors hold Heron Therapeutics Inc for approximately 12 days, indicating typical investor behavior on the platform.

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Technical Indicators

Overall Summary

Bearish (12)Neutral (2)Bullish (13)

News

Zacks Investment2 year ago

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

Zacks Investment2 year ago

AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer

Zacks Investment2 year ago

Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?

Zacks Investment2 year ago

FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder

Zacks Investment2 year ago

OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$148.94M
Sector
Health
3M Drawdown
-49.94%
Enterprise Value
$244.00M
Dividend Yield
-
Trading Activity
85% Buy | 15% Sell
Typical Hold Time
12 days

$0.85

52W Low: $0.75

30 Mar 2026

52W High: $2.42

06 May 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Heron Therapeutics Inc (HRTX) – Heron Therapeutics Inc Price Today

Aura AI Summary

Key Stats

About Heron Therapeutics Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store